The influence of Schisandrin B on a model of Alzheimer’s disease using β-amyloid protein Aβ1-42-mediated damage in SH-SY5Y neuronal cell line and underlying mechanisms
- 7 September 2017
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 80 (22) , 1199-1205
Abstract
Schisandrin B, an active substance, is derived from Chinese herb fruit Wuweizi, which exerts various pharmacological activities and has displayed significant beneficial effects in ameliorating Alzheimer’s disease (AD). The aim of this study was to further extend our examination for the use of schisandrin B extract in the potential treatment of AD effects by investigating DNA methylation (DNMT), known to be modified in this disease using SH-SY5Y neuronal cell line exposed to β-amyloid protein (Aβ1-42). In particular, the purpose of this investigation was to examine alterations in mRNA and protein expression of DNMT. Data demonstrated that schisandrin B blocked Aβ1-42-mediated injury in SH-SY5Y neuronal cell line as evidenced by a restoration of cellular morphology and cell viability to approximate control levels at the highest 10 μg/ml Schisandrin B. Incubation with Aβ1-42 significantly decreased mRNA and protein expression of DNMT3A and DNMT1 in SH-SY5Y neuronal cell line. Incubation with Aβ1-42 followed by 24 treatment with schisandrin B significantly inhibited the Aβ1-42 -induced changes in mRNA and protein expression of DNMT3A and DNMT3B in a concentration-dependent manner. It is of interest that the mRNA expression of DNMT3A and DNMT1 were significantly higher than control. Data thus indicate schisandrin B was effective in inhibiting the actions of Aβ1-42 on cell survival and morphology and that DNA methylation may be associated with the beneficial findings.Keywords
Funding Information
- National Natural Science Foundation of China (81560195)
- Scientific Foundation in Baotou Medical College (BYJJ-QM201633)
- Medicine and Health Foundation in Baotou (Wsjj2015018)
This publication has 8 references indexed in Scilit:
- Current advances in transdermal delivery of drugs for Alzheimer's diseaseIndian Journal of Pharmacology, 2017
- Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer’s ModelScientific Reports, 2016
- The Effect of Schizandrol A-Induced DNA Methylation on SH-SY5YAB 1-40 Altered Neuronal Cell Line: A Potential Use in Alzheimer’s DiseaseJournal of Toxicology and Environmental Health, Part A, 2015
- Epigenomics of Alzheimer's diseaseTranslational Research, 2015
- Mitochondrial Toxic Effects of Aβ Through Mitofusins in the Early Pathogenesis of Alzheimer’s DiseaseMolecular Neurobiology, 2014
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkersBiochemical Pharmacology, 2014
- Evolution in the Conceptualization of Dementia and Alzheimer’s Disease: Greco-Roman Period to the 1960sNeurobiology of Aging, 1998
- Cell Biology of the Amyloid beta-Protein Precursor and the Mechanism of Alzheimer's DiseaseAnnual Review of Cell Biology, 1994